HESI THRIVE 2025 Seed Grant Program – Funding Opportunity for Innovative Cancer Research
Health and Environmental Sciences Institute (HESI) shared a post on LinkedIn:
“Are you conducting innovative research aimed at predicting, preventing, or reducing unintended adverse effects of cancer therapies? The Health and Environmental Sciences Institute (HESI) THRIVE 2025 Seed Grant program is accepting Letters of Intent through April 7th, 2025.
This global funding opportunity offers up to $50,000 USD in seed support to early-stage, high-impact projects in basic, clinical, or translational cancer research. Through the THRIVE program, HESI aims to catalyze science that enhances patient well-being and advances safer cancer treatment strategies—core to our mission of collaboratively addressing global health challenges.
Eligibility: MDs, PhDs, DVMs, and international Principal Investigator collaborations are welcome.
Deadline to submit LOI: April 7, 2025
Explore projects from last year’s awardees.
Submit your LOI here.
Don’t miss your chance to join a growing community of researchers transforming cancer care through collaborative science and innovation.”
Syril Pettit, Executive Director of Health and Environmental Sciences Institute, shared a post by HESI on LinkedIn:
“Seeking funding for cancer survivorship research? Seeking to improve patient QoL by reducing or eliminating treatment-related toxicities? Deadline for LOIs is April 7 – apply now.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023